Genes, Hormones and Breast Cancer Risk

基因、激素和乳腺癌风险

基本信息

项目摘要

DESCRIPTION (provided by applicant): Dr. Wendy Setiawan received her Ph.D. in epidemiology from UCLA in 2002. She completed a year of postdoctoral training at Harvard and is currently at the Department of Preventive Medicine at USC where she is part of the highly interactive population/cancer genetics group headed by Dr. Brian E. Henderson. The goal of this career development award is to provide Dr. Setiawan with the knowledge and necessary skills to become an independent cancer researcher. A combination of research project, structured courses, seminars, workshops, and mentoring has been designed to accomplish this goal. Two highly qualified and experienced mentors with relevant expertise, Dr. Henderson (cancer epidemiology) and Dr. Duncan Thomas (biostatistics and genetics), will supervise her training. The scientific culture and collaborative research atmosphere in the department provide an ideal environment for the candidate's academic career development. The objective of Dr. Setiawan's research project is to identify environmental and genetic determinants of circulating endogenous sex-steroid hormone levels, because there are substantial inter-individual variations in circulating hormone levels and postmenopausal women with elevated estrogens and androgens are at an increased risk of breast cancer. A cross-sectional study of healthy postmenopausal women from the Multiethnic Cohort Study (MEC) will be conducted to 1) determine whether known/potential breast cancer risk factors are associated with plasma hormone levels, 2) characterize genetic variation of estrogen biosynthesis genes (CYP11A, CYP17, CYP19, HSD3B1, HSD3B2, HSD17B1, HSD17B2, and SHBG) using a two-pronged approach (putative functional variants and inferred haplotypes) and evaluate these in relation to hormone levels; 3) develop and implement a Bayesian hierarchical statistical model that allows for an efficient and pathway-driven examination of multiple gene-gene and a priori gene-environment interactions in influencing hormone levels. The unique feature of the proposed study is that it integrates a large multiethnic population-based study, cutting edge genomic resources, and novel statistical approaches to identify genetic and environmental factors responsible for inter-individual variations in endogenous hormone levels. Identification of these factors is important to understand the mechanisms by which they could influence breast cancer risk and ultimately to identify high-risk women for prevention strategies.
描述(由申请人提供):Wendy Setiawan博士获得博士学位。她于2002年获得加州大学洛杉矶分校(UCLA)的流行病学。该职业发展奖的目标是为Setiawan博士提供成为独立癌症研究员的知识和必要技能。研究项目,结构化课程,研讨会,研讨会和指导的结合旨在实现这一目标。两位具有相关专业知识的高素质和经验丰富的导师Henderson博士(癌症流行病学)和Duncan Thomas博士(生物统计学和遗传学)将监督她的培训。该部门的科学文化和协作研究氛围为候选人的学术职业发展提供了理想的环境。 Setiawan博士的研究项目的目的是确定循环内源性性类固醇激素水平的环境和遗传决定因素,因为循环激素水平和绝经后妇女的雌激素和雄激素升高的循环激素水平和雄激素升高的妇女存在实质性的差异。 A cross-sectional study of healthy postmenopausal women from the Multiethnic Cohort Study (MEC) will be conducted to 1) determine whether known/potential breast cancer risk factors are associated with plasma hormone levels, 2) characterize genetic variation of estrogen biosynthesis genes (CYP11A, CYP17, CYP19, HSD3B1, HSD3B2, HSD17B1, HSD17B2和SHBG)使用两管齐下的方法(假定的功能变体和推断的单倍型),并根据激素水平评估这些方法; 3)开发和实施一个贝叶斯分层统计模型,该模型允许对多个基因基因和先验基因 - 环境相互作用进行有效且驱动途径驱动的统计模型。拟议的研究的独特特征是,它整合了一项大型基于多种族的研究,最先进的基因组资源以及新型的统计方法,以鉴定负责内源激素水平的个体间变异的遗传和环境因素。这些因素的识别对于了解它们可以影响乳腺癌风险的机制很重要,并最终确定高危女性以预防策略。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Alcohol consumption and endometrial cancer risk: the multiethnic cohort.
饮酒和子宫内膜癌风险:多种族队列。
  • DOI:
    10.1002/ijc.23072
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Setiawan,VeronicaWendy;Monroe,KristineR;Goodman,MarcT;Kolonel,LaurenceN;Pike,MalcolmC;Henderson,BrianE
  • 通讯作者:
    Henderson,BrianE
Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort.
  • DOI:
    10.1002/ijc.24718
  • 发表时间:
    2010-01-15
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Park, Sungshim Lani;Goodman, Marc T.;Zhang, Zuo-Feng;Kolonel, Laurence N.;Henderson, Brian E.;Setiawan, Veronica Wendy
  • 通讯作者:
    Setiawan, Veronica Wendy
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VERONICA WENDY SETIAWAN其他文献

VERONICA WENDY SETIAWAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VERONICA WENDY SETIAWAN', 18)}}的其他基金

Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
西班牙裔晚期 NAFLD 差异的机制:多层次分析
  • 批准号:
    10530687
  • 财政年份:
    2021
  • 资助金额:
    $ 13.08万
  • 项目类别:
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
西班牙裔晚期 NAFLD 差异的机制:多层次分析
  • 批准号:
    10323053
  • 财政年份:
    2021
  • 资助金额:
    $ 13.08万
  • 项目类别:
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
使用循环 MicroRNA 进行胰腺癌的早期检测和风险评估
  • 批准号:
    10541824
  • 财政年份:
    2019
  • 资助金额:
    $ 13.08万
  • 项目类别:
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
使用循环 MicroRNA 进行胰腺癌的早期检测和风险评估
  • 批准号:
    10321615
  • 财政年份:
    2019
  • 资助金额:
    $ 13.08万
  • 项目类别:
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
了解未充分研究和高危人群中肝癌和慢性肝病的种族/民族差异的决定因素
  • 批准号:
    10112841
  • 财政年份:
    2018
  • 资助金额:
    $ 13.08万
  • 项目类别:
Contribution of Racial Disparity Towards the Early Development of Pancreatic Cancer
种族差异对胰腺癌早期发展的贡献
  • 批准号:
    10006120
  • 财政年份:
    2018
  • 资助金额:
    $ 13.08万
  • 项目类别:
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence
调查胰腺癌发病率种族/民族差异的原因
  • 批准号:
    9300756
  • 财政年份:
    2017
  • 资助金额:
    $ 13.08万
  • 项目类别:
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
调查肝细胞癌风险中种族/民族差异的原因
  • 批准号:
    8829805
  • 财政年份:
    2014
  • 资助金额:
    $ 13.08万
  • 项目类别:
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
调查肝细胞癌风险中种族/民族差异的原因
  • 批准号:
    8704088
  • 财政年份:
    2014
  • 资助金额:
    $ 13.08万
  • 项目类别:
Type 1 and Type 2 Endometrial Cancer: Have They Different Risk Factors? A Pooled
1 型和 2 型子宫内膜癌:它们有不同的危险因素吗?
  • 批准号:
    7659200
  • 财政年份:
    2009
  • 资助金额:
    $ 13.08万
  • 项目类别:

相似海外基金

Role of YB1 in health disparities in triple negative breast cancer
YB1 在三阴性乳腺癌健康差异中的作用
  • 批准号:
    10655943
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
DELINEATING THE ROLE OF THE HOMOCYSTEINE-FOLATE-THYMIDYLATE SYNTHASE AXIS AND URACIL ACCUMULATION IN AFRICAN AMERICAN PROSTATE TUMORS
描述同型半胱氨酸-叶酸-胸苷酸合成酶轴和尿嘧啶积累在非裔美国人前列腺肿瘤中的作用
  • 批准号:
    10723833
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
加强药物管理以控制非裔美国人和拉丁裔的 ADRD 风险因素
  • 批准号:
    10610975
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
  • 批准号:
    10577022
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
Racial Disparities in Alzheimer's Disease and Related Dementias: The Role of School Segregation and Experiences of Discrimination
阿尔茨海默病和相关痴呆症的种族差异:学校隔离的作用和歧视经历
  • 批准号:
    10606362
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了